Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook

4Q 2023 operating revenue of $42.5 billion, up 7.0% from 4Q 2022; FY 2023 operating revenue of $170 billion, up 9.3% from FY 2022



4Q 2023 GAAP diluted EPS1 of $3.63, up 1.1% from 4Q 2022 and...

Related Keywords

Gailk Boudreaux , ,Carelon Services ,Elevance Health On Linkedin ,Carelon Services Consumers ,Health Products Services ,Employer Group ,Elevance Health ,Employer Group Fee ,International Replay ,Carelon Global Solutions ,Elevance Health Inc ,Administration Members ,Service Fees ,Employer Group Risk ,Chief Executive Officer ,Health Benefits ,Claims Payable ,Federal Health Products ,Carelon Global ,Reportable Segment Highlight Details ,Commercial Health Benefits ,Affordable Care Act ,Operating Gain ,Standard Time ,Domestic Replay ,Release Financial Schedules ,Year Ended December ,Full Year Consolidated Statements ,Consolidated Statement ,Financial Information ,Medical Claims ,Disability Members ,Months Ended December ,Operating Revenue ,Ended December ,Shareholder Net Income ,Shareholder Net Income Per Share ,Operating Expense ,Total Revenue ,Consolidated Statements ,Accounting Standards Update ,End Medical Enrollment ,Pre Tax Items ,Intangible Assets ,Markets ,